Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.5 SEK | -2.90% | +11.30% | -35.58% |
05-15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.58% | 211M | |
-4.27% | 12.33B | |
-4.35% | 8.14B | |
+32.26% | 5.62B | |
-7.42% | 4.24B | |
-54.50% | 3.06B | |
+14.44% | 2.76B | |
-1.75% | 2.41B | |
+30.85% | 2.23B | |
-4.67% | 1.87B |
- Stock Market
- Equities
- GENO Stock
- News Genovis AB
- Genovis to Get $1 Million Milestone Payment for Xork Development